Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Objective Ovarian cancers comprise several histologically distinct tumour groups with widely different prognosis. We aimed to describe the worldwide distribution of ovarian cancer histology and to understand what role this may play in international variation in survival. Methods The CONCORD programme is the largest population-based study of global trends in cancer survival. Data on 681,759 women diagnosed during 1995–2009 with cancer of the ovary, fallopian tube, peritoneum and retroperitonum in 51 countries were included. We categorised ovarian tumours into six histological groups, and explored the worldwide distribution of histology. Results During 2005–2009, type II epithelial tumours were the most common. The proportion was much higher in Oceania (73.1%), North America (73.0%) and Europe (72.6%) than in Central and South America (65.7%) and Asia (56.1%). By contrast, type I epithelial tumours were more common in Asia (32.5%), compared with only 19.4% in North America. From 1995 to 2009, the proportion of type II epithelial tumours increased from 68.6% to 71.1%, while the proportion of type I epithelial tumours fell from 23.8% to 21.2%. The proportions of germ cell tumours, sex cord-stromal tumours, other specific non-epithelial tumours and tumours of non-specific morphology all remained stable over time. Conclusions The distribution of ovarian cancer histology varies widely worldwide. Type I epithelial, germ cell and sex cord-stromal tumours are generally associated with higher survival than type II tumours, so the proportion of these tumours may influence survival estimates for all ovarian cancers combined. The distribution of histological groups should be considered when comparing survival between countries and regions.
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Matz, Melissa;Coleman, Michel P;Sant, Milena;Chirlaque, Maria Dolores;Visser, Otto;Gore, Martin;Allemani;Claudia & S. Bouzbid;M. Hamdi-Chérif;Z. Zaidi;E. Bah;R. Swaminathan;S. H. Nortje;D. C. Stefan;M. M. El Mistiri;S. Bayo;B. Malle;S. S. Manraj;R. Sewpaul-Sungkur;A. Fabowale;O. J. Ogunbiyi;D. Bradshaw;N. I. M. Somdyala;M. Abdel-Rahman;L. Jaidane;M. Mokni;I. Kumcher;F. Moreno;M. S. González;E. A. Laura;S. B. Espinola;G. H. Calabrano;B. Carballo Quintero;R. Fita;D. A. Garcilazo;P. L. Giacciani;M. C. Diumenjo;W. D. Laspada;M. A. Green;M. F. Lanza;S. G. Ibañez;C. A. Lima;E. Lobo de Oliveira;C. Daniel;C. Scandiuzzi;P. C. F. De Souza;C. D. Melo;K. Del Pino;C. Laporte;M. P. Curado;J. C. de Oliveira;C. L. A. Veneziano;D. B. Veneziano;T. S. Alexandre;A. S. Verdugo;G. Azevedo e Silva;J. C. Galaz;J. A. Moya;D. A. Herrmann;S. Vargas;V. M. Herrera;C. J. Uribe;L. E. Bravo;N. E. Arias-Ortiz;D. M. Jurado;M. C. Yépez;Y. H. Galán;P. Torres;F. Martínez-Reyes;M. L. Pérez-Meza;L. Jaramillo;R. Quinto;P. Cueva;J. G. Yépez;C. R. Torres-Cintrón;G. Tortolero-Luna;R. Alonso;E. Barrios;C. Nikiforuk;L. Shack;A. J. Coldman;R. R. Woods;G. Noonan;D. Turner;E. Kumar;B. Zhang;F. R. McCrate;S. Ryan;H. Hannah;R. A. D. Dewar;M. MacIntyre;A. Lalany;M. Ruta;L. Marrett;D. E. Nishri;C. McClure;K. A. Vriends;C. Bertrand;R. Louchini;K. I. Robb;H. Stuart-Panko;S. Demers;S. Wright;J. T. George;X. Shen;J. T. Brockhouse;D. K. O'Brien;K. C. Ward;L. Almon;J. Bates;R. Rycroft;L. Mueller;C. Phillips;H. Brown;B. Cromartie;A. G. Schwartz;F. Vigneau;J. A. MacKinnon;B. Wohler;A. R. Bayakly;C. A. Clarke;S. L. Glaser;D. West;M. D. Green;B. Y. Hernandez;C. J. Johnson;D. Jozwik;M. E. Charlton;C. F. Lynch;B. Huang;T. C. Tucker;D. Deapen;L. Liu;M. C. Hsieh;X. C. Wu;K. Stern;S. T. Gershman;R. C. Knowlton;J. Alverson;G. E. Copeland;D. B. Rogers;D. Lemons;L. L. Williamson;M. Hood;G. M. Hosain;J. R. Rees;K. S. Pawlish;A. Stroup;C. Key;C. Wiggins;A. R. Kahn;M. J. Schymura;G. Leung;C. Rao;L. Giljahn;B. Warther;A. Pate;M. Patil;S. S. Schubert;J. J. Rubertone;S. J. Slack;J. P. Fulton;D. L. Rousseau;T. A. Janes;S. M. Schwartz;S. W. Bolick;D. M. Hurley;J. Richards;M. A. Whiteside;L. M. Nogueira;K. Herget;C. Sweeney;J. Martin;S. Wang;D. G. Harrelson;M. B. Keitheri Cheteri;S. Farley;A. G. Hudson;R. Borchers;L. Stephenson;J. R. Espinoza;H. K. Weir;B. K. Edwards;N. Wang;L. Yang;J. S. Chen;G. H. Song;X. P. Gu;P. Zhang;H. M. Ge;D. L. Zhao;J. H. Zhang;F. D. Zhu;J. G. Tang;Y. Shen;J. Wang;Q. L. Li;X. P. Yang;J. Dong;W. Li;L. P. Cheng;J. G. Chen;Q. H. Huang;S. Q. Huang;G. P. Guo;K. Wei;W. Q. Chen;H. Zeng;A. V. Demetriou;P. Pavlou;W. K. Mang;K. C. Ngan;R. Swaminathan;A. C. Kataki;M. Krishnatreya;P. A. Jayalekshmi;P. Sebastian;S. D. Sapkota;Y. Verma;A. Nandakumar;E. Suzanna;L. Keinan-Boker;B. G. Silverman;H. Ito;H. Nakagawa;M. Hattori;Y. Kaizaki;H. Sugiyama;M. Utada;K. Katayama;H. Narimatsu;S. Kanemura;T. Koike;I. Miyashiro;M. Yoshii;I. Oki;A. Shibata;T. Matsuda;O. Nimri;A. Ab Manan;N. Bhoo Pathy;O. Chimedsuren;S. Tuvshingerel;A. H. M. Al Khater;M. M. El Mistiri;H. Al-Eid;K. W. Jung;Y. J. Won;C. J. Chiang;M. S. Lai;K. Suwanrungruang;S. Wiangnon;K. Daoprasert;D. Pongnikorn;S. L. Geater;H. Sriplung;S. Eser;C. I. Yakut;M. Hackl;H. Mühlböck;W. Oberaigner;A. A. Zborovskaya;O. V. Aleinikova;K. Henau;L. Van Eycken;N. Dimitrova;Z. Valerianova;M. Šekerija;M. Zvolský;G. Engholm;H. Storm;K. Innos;M. Mägi;N. Malila;K. Seppä;J. Jégu;M. Velten;E. Cornet;X. Troussard;A. M. Bouvier;J. Faivre;A. V. Guizard;V. Bouvier;G. Launoy;P. Arveux;M. Maynadié;M. Mounier;E. Fournier;A. S. Woronoff;M. Daoulas;J. Clavel;S. Le Guyader-Peyrou;A. Monnereau;B. Trétarre;M. Colonna;A. Cowppli-Bony;F. Molinié;S. Bara;D. Degré;O. Ganry;B. Lapôtre-Ledoux;P. Grosclaude;J. Estève;F. Bray;M. Piñeros;F. Sassi;R. Stabenow;A. Eberle;C. Erb;A. Nennecke;J. Kieschke;E. Sirri;H. Kajueter;K. Emrich;S. R. Zeissig;B. Holleczek;N. Eisemann;A. Katalinic;H. Brenner;R. A. Asquez;V. Kumar;E. J. Ólafsdóttir;L. Tryggvadóttir;H. Comber;P. M. Walsh;H. Sundseth;E. Devigili;G. Mazzoleni;A. Giacomin;F. Bella;M. Castaing;A. Sutera;G. Gola;S. Ferretti;D. Serraino;A. Zucchetto;R. Lillini;M. Vercelli;S. Busco;F. Pannozzo;S. Vitarelli;P. Ricci;C. Pascucci;M. Autelitano;C. Cirilli;M. Federico;M. Fusco;M. F. Vitale;M. Usala;R. Cusimano;W. Mazzucco;M. Michiara;P. Sgargi;M. M. Maule;C. Sacerdote;R. Tumino;E. Di Felice;M. Vicentini;F. Falcini;L. Cremone;M. Budroni;R. Cesaraccio;M. L. Contrino;F. Tisano;A. C. Fanetti;S. Maspero;G. Candela;T. Scuderi;M. A. Gentilini;S. Piffer;S. Rosso;L. Sacchetto;A. Caldarella;F. La Rosa;F. Stracci;P. Contiero;G. Tagliabue;A. P. Dei Tos;M. Zorzi;R. Zanetti;P. Baili;F. Berrino;G. Gatta;M. Sant;R. Capocaccia;R. De Angelis;E. Liepina;A. Maurina;G. Smailyte;D. Agius;N. Calleja;S. Siesling;O. Visser;S. Larønningen;B. Møller;A. Dyzmann-Sroka;M. Trojanowski;S. Góźdż;R. Mężyk;M. Grądalska-Lampart;A. U. Radziszewska;J. A. Didkowska;U. Wojciechowska;J. Błaszczyk;K. Kępska;M. Bielska-Lasota;K. Kwiatkowska;G. Forjaz;R. A. Rego;J. Bastos;M. A. Silva;L. Antunes;M. J. Bento;A. Mayer-da-Silva;A. Miranda;D. Coza;A. I. Todescu;M. Y. Valkov;J. Adamcik;C. Safaei Diba;M. Primic-Žakelj;T. Žagar;J. Stare;E. Almar;A. Mateos;J. R. Quirós;J. Bidaurrazaga;N. Larrañaga;J. M. Díaz García;A. I. Marcos;R. Marcos-Gragera;M. L. Vilardell Gil;E. Molina;M. J. Sánchez;P. Franch Sureda;M. Ramos Montserrat;M. D. Chirlaque;C. Navarro;E. E. Ardanaz;C. C. Moreno-Iribas;R. Fernández-Delgado;R. Peris-Bonet;J. Galceran;S. Khan;M. Lambe;B. Camey;C. Bouchardy;M. Usel;S. M. Ess;C. Herrmann;J. L. Bulliard;M. Maspoli-Conconi;H. Frick;C. E. Kuehni;M. Schindler;A. Bordoni;A. Spitale;A. Chiolero;I. Konzelmann;S. I. Dehler;K. L. Matthes;J. Rashbass;C. Stiller;D. Fitzpatrick;A. Gavin;F. Bannon;R. J. Black;D. H. Brewster;D. W. Huws;C. White;P. Finan;C. Allemani;A. Bonaventure;H. Carreira;M. P. Coleman;V. Di Carlo;R. Harewood;K. Liu;M. Matz;L. Montel;M. Nikšić;B. Rachet;N. Sanz;D. Spika;R. Stephens;M. Peake;E. Chalker;L. Newman;D. Baker;M. J. Soeberg;J. Aitken;C. Scott;B. C. Stokes;A. Venn;H. Farrugia;G. G. Giles;T. Threlfall;D. Currow;H. You;J. Hendrix;C. Lewis
2017-01-01
Abstract
Objective Ovarian cancers comprise several histologically distinct tumour groups with widely different prognosis. We aimed to describe the worldwide distribution of ovarian cancer histology and to understand what role this may play in international variation in survival. Methods The CONCORD programme is the largest population-based study of global trends in cancer survival. Data on 681,759 women diagnosed during 1995–2009 with cancer of the ovary, fallopian tube, peritoneum and retroperitonum in 51 countries were included. We categorised ovarian tumours into six histological groups, and explored the worldwide distribution of histology. Results During 2005–2009, type II epithelial tumours were the most common. The proportion was much higher in Oceania (73.1%), North America (73.0%) and Europe (72.6%) than in Central and South America (65.7%) and Asia (56.1%). By contrast, type I epithelial tumours were more common in Asia (32.5%), compared with only 19.4% in North America. From 1995 to 2009, the proportion of type II epithelial tumours increased from 68.6% to 71.1%, while the proportion of type I epithelial tumours fell from 23.8% to 21.2%. The proportions of germ cell tumours, sex cord-stromal tumours, other specific non-epithelial tumours and tumours of non-specific morphology all remained stable over time. Conclusions The distribution of ovarian cancer histology varies widely worldwide. Type I epithelial, germ cell and sex cord-stromal tumours are generally associated with higher survival than type II tumours, so the proportion of these tumours may influence survival estimates for all ovarian cancers combined. The distribution of histological groups should be considered when comparing survival between countries and regions.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11581/418525
Citazioni
47
104
101
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.